ArticleEvidence-based medicine2011

Eplerenone reduces risk of cardiovascular death or hospitalisation in heart failure patients with reduced ejection fraction.

Andrew Ambrosy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.